Unaudited Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 551,636	$ 537,198
Accounts receivable		1,850,375
Other current assets	14,781	17,180
Total current assets	566,417	2,404,753
Patents, net of accumulated amortization of $1,756,018 and $1,617,762, respectively	2,616,098	2,754,354
Total assets	3,182,515	5,159,107
Current liabilities:
Accounts payable and accrued liabilities	2,120,363	3,362,932
Loans payable - third party	147,000	147,000
Purchase price of patents, current portion, net of unamortized discount of $23,392 and $0 respectively	951,608	569,386
Loan payable - related party, net of unamortized discount and debt issuance costs of $131,780 and $189,705, respectively	4,541,030	4,483,105
Accrued interest - loans payable related party	116,500	117,780
Accrued interest - loans payable third party	273,860	270,185
Derivative liability	635,000	595,000
Total current liabilities	8,785,361	9,545,388
Non-current liabilities
Contingent funding liabilities	20,378	20,378
Purchase price of patents, net of unamortized discount of $216,270 and $282,503, respectively	908,730	1,442,497
Total liabilities	9,714,469	11,008,263
Stockholders' deficit:
Preferred stock, par value $.00003 per share, authorized 10,000,000 shares, no shares issued and outstanding
Common stock, par value $0.00003 per share; authorized 10,000,000,000 shares at March 31, 2020 and December 31, 2019; shares issued and outstanding 383,038,334 at March 31, 2020 and December 31, 2019	11,491	11,491
Additional paid-in capital	14,107,782	14,107,782
Accumulated deficit	(20,651,466)	(19,968,668)
Total Quest Patent Research Corporation deficit	(6,532,193)	(5,849,395)
Non-controlling interest in subsidiary	239	239
Total stockholders' deficit	(6,531,954)	(5,849,156)
Total liabilities and stockholders' deficit	$ 3,182,515	$ 5,159,107